OGFOD1 modulates the transcriptional and proteomic landscapes to alter isoproterenol-induced hypertrophy susceptibility

J Mol Cell Cardiol. 2023 Jun:179:42-46. doi: 10.1016/j.yjmcc.2023.04.002. Epub 2023 Apr 19.

Abstract

Cardiac hypertrophy is associated with increased translation. However, little is known of the mechanisms that regulate translation in hypertrophy. Members of the 2-oxoglutarate-dependent dioxygenase family regulate several aspects of gene expression, including translation. An important member of this family is OGFOD1. Here, we show OGFOD1 accumulates in failing human hearts. Upon OGFOD1 deletion, murine hearts showed transcriptomic and proteomic changes, with only 21 proteins and mRNAs (0.6%) changing in the same direction. Additionally, OGFOD1-KO mice were protected from induced hypertrophy, supporting a role for OGFOD1 in the cardiac response to chronic stress.

Keywords: Cardiac hypertrophy; Heart failure; Post-translational modifications; Proline hydroxylation; Translation.

Publication types

  • Research Support, N.I.H., Intramural

MeSH terms

  • Animals
  • Cardiomegaly / metabolism
  • Heart
  • Humans
  • Isoproterenol / adverse effects
  • Mice
  • Myocytes, Cardiac / metabolism
  • Nuclear Proteins* / metabolism
  • Proteomics*

Substances

  • Isoproterenol
  • Nuclear Proteins
  • OGFOD1 protein, human
  • proline, 2-oxoglutarate 3-dioxygenase
  • Ogfod1 protein, mouse